F18.951
Inhalant use, unspecified with inhalant-induced psychotic disorder with hallucinations
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F18.951 pertains to a condition where an individual experiences psychotic symptoms, particularly hallucinations, due to inhalant use. Inhalants are substances that produce chemical vapors which can be inhaled to achieve mind-altering effects. This diagnosis indicates that the inhalant use has led to significant mental health disturbances, specifically hallucinations, which are perceptions of things that are not present in reality. Recognizing and understanding this condition is essential for appropriate treatment and management.
Causes & Symptoms
Clinical Causes: Use of inhalant substances such as glue, aerosol sprays, nitrous oxide, solvent fumes, or chemicals. Prolonged or heavy inhalant use leading to neurochemical alterations and mental health issues. Pre-existing mental health conditions that may increase vulnerability to substance-induced psychosis. Environmental or social factors that promote inhalant use, especially in adolescents or vulnerable populations.
Key Symptoms: Hallucinations, often visual or auditory, where the individual perceives things that are not present. Confusion or disorientation concerning reality. Delusional beliefs related to the hallucinations or the effects of inhalant use. Mood swings or agitation that can occur during or after inhalant use. Impaired judgment and decreased social functioning. Physical symptoms such as dizziness, nausea, or slurred speech during inhalant intoxication.
Diagnostic & Treatment
Diagnosis Path: Diagnosis is primarily based on clinical evaluation, including a detailed history of inhalant use and mental health symptoms. Healthcare professionals may perform physical examinations, laboratory tests, or neuroimaging to rule out other causes. The presence of psychotic symptoms in conjunction with recent inhalant use supports the diagnosis. It is essential to differentiate this condition from primary psychotic disorders or other mental health issues.
Treatment Protocols: Treatment typically involves a combination of approaches aimed at addressing both substance use and psychotic symptoms. Interventions may include counseling, behavioral therapies, and support groups to promote inhalant abstinence. In some cases, medications such as antipsychotics may be prescribed to control hallucinations and psychosis. Ongoing mental health support and rehabilitation programs are vital for recovery and preventing relapse.
Clinical Advice & FAQs
Billing Guidance
Is F18.951 a billable ICD-10 code?
Yes, F18.951 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.951?
Clinical documentation must specify the nature of Inhalant use, unspecified with inhalant-induced psychotic disorder with hallucinations and any associated comorbidities for accurate reporting.
Cite this Clinical Reference